Metrovacesa S.A. (BME:MVC)
10.92
-0.20 (-1.80%)
Aug 3, 2026, 5:35 PM CET
Metrovacesa Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 159.82 | 194.06 | 186.43 | 196.3 | 202.01 | 299.55 |
Short-Term Investments | - | - | 88.56 | 36.93 | - | 37.98 |
Cash & Short-Term Investments | 159.82 | 194.06 | 274.99 | 233.23 | 202.01 | 337.53 |
Cash Growth | -17.65% | -29.43% | 17.90% | 15.45% | -40.15% | 1.04% |
Accounts Receivable | 89.21 | 76.22 | - | 62.65 | 41.47 | - |
Other Receivables | - | - | 10.51 | - | - | 18.89 |
Total Trade Receivables | 89.21 | 76.22 | 10.51 | 62.65 | 41.47 | 18.89 |
Inventory | 1,463 | 1,570 | 1,740 | 1,826 | 1,843 | 1,844 |
Other Current Assets | - | - | - | 15.26 | 20.03 | - |
Total Current Assets | 1,739 | 1,874 | 2,025 | 2,137 | 2,106 | 2,200 |
Net Property, Plant & Equipment | 258.13 | 248.35 | 244.01 | 243.17 | 242.4 | 418.64 |
Other Intangible Assets | 0.33 | 0.36 | - | 0.3 | 0.5 | - |
Long-Term Investments | 52.19 | 49.5 | 64.87 | 49.03 | 85.19 | 73.58 |
Other Long-Term Assets | 70.33 | 70.63 | 79.22 | 82.05 | 79.61 | 84.33 |
Total Assets | 2,131 | 2,258 | 2,414 | 2,533 | 2,514 | 2,777 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 100.37 | 97.91 | - | 100.92 | 357.38 | - |
Accrued Expenses | - | - | - | 21.02 | 185.8 | - |
Short-Term Debt | 34.64 | 65.88 | - | 46.29 | 29 | - |
Current Portion of Long-Term Debt | - | - | 431.28 | - | 74.38 | 323.64 |
Other Current Liabilities | 274.93 | 242.67 | 75.43 | 228.71 | 45.77 | 40.09 |
Total Current Liabilities | 530.48 | 521.45 | 506.71 | 555.4 | 382.11 | 363.72 |
Long-Term Debt | - | - | 291.7 | - | 273.89 | 287.44 |
Other Long-Term Liabilities | 69.83 | 68.67 | 18.23 | 58.33 | 53.09 | 46.18 |
Total Long-Term Liabilities | 303.99 | 322.38 | 309.93 | 291.96 | 326.23 | 333.62 |
Total Liabilities | 834.48 | 843.82 | 816.64 | 847.36 | 708.34 | 697.34 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,092 | 1,092 | 1,092 | 1,092 | 1,092 | 1,092 |
Treasury Stock | -0.43 | -1.43 | -1.17 | -1.67 | -2.56 | -2.7 |
Additional Paid-in Capital | 390.2 | 526.76 | 766.07 | 870.9 | 971.22 | 1,222 |
Retained Earnings | -185.4 | -203.24 | -260.1 | -275.98 | -255.19 | -231.75 |
Total Common Shareholders' Equity | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Shareholders' Equity | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Total Liabilities & Equity | 2,131 | 2,258 | 2,414 | 2,533 | 2,514 | 2,777 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 34.64 | 65.88 | 722.98 | 46.29 | 377.27 | 611.08 |
Net Cash (Debt) | 125.18 | 128.18 | -447.99 | 186.94 | -175.25 | -273.55 |
Net Cash Growth | -2.34% | - | - | - | - | - |
Net Cash Per Share | 0.54 | 0.85 | -2.96 | 1.23 | -1.16 | -1.81 |
Book Value | 1,296 | 1,414 | 1,597 | 1,685 | 1,806 | 2,080 |
Book Value Per Share | 5.57 | 9.33 | 10.54 | 11.13 | 11.92 | 13.73 |
Tangible Book Value | 1,296 | 1,414 | 1,597 | 1,685 | 1,805 | 2,080 |
Tangible Book Value Per Share | 5.57 | 9.33 | 10.54 | 11.12 | 11.92 | 13.73 |